CLOROX CO /DE/ (CLX) — Current Report

AI-Powered SEC Filing Analysis

← All CLX filings

Want the newest filings?

This analysis covers the filing from 2026-04-30. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Current Report filings

Filed: 2026-04-01
  • Clorox has completed the acquisition of GOJO Industries, the maker of Purell, a leading brand in the hand sanitizer and hygiene products market.
  • The acquisition of GOJO Industries aligns with Clorox's strategy to expand its portfolio of essential consumer products and strengthen its position in the growing hygiene and disinfection category.
  • The transaction is likely to provide Clorox with new growth opportunities and synergies as it integrates GOJO's products and operations with its existing business.
Filed: 2026-03-10
  • Clorox is acquiring GOJO Industries, the maker of PURELL, in a significant transaction that will expand its consumer health and wellness portfolio.
  • The company has secured $2.25 billion in new credit facilities, including a $1 billion 364-day revolving credit agreement and a $1.25 billion delayed draw term credit agreement, to finance the acquisition and support general corporate purposes.
  • The credit agreements contain customary covenants and events of default, with the key financial covenant being a consolidated interest coverage ratio.
Filed: 2026-02-03
  • Clorox reported Q2 2025 financial results, with details on revenue, earnings, and other key metrics.
  • The company provided an update on its business operations and any notable events or developments during the quarter.
  • Investors should review the supplemental financial information provided to gain additional context around the quarterly performance.
Filed: 2026-01-22
  • Clorox announced the acquisition of GOJO Industries, Inc., the maker of PURELL, for $2.25 billion in cash, which is expected to significantly expand Clorox's presence in the hand sanitizer and personal hygiene product categories.
  • The acquisition is expected to be funded primarily through debt financing and is subject to regulatory approval and other customary closing conditions.
  • Clorox reaffirmed its fiscal year 2026 outlook for net sales, diluted EPS, and adjusted EPS, indicating the company's confidence in its financial performance despite the acquisition.

Other reports for CLOROX CO /DE/

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.